In vivo efficacy testing of mycoxotoxin binders in poultry by means of a toxicokinetic study according to EFSA guidelines by Devreese, Mathias et al.
In vivo efficacy testing of mycotoxin binders in poultry by 
means of a toxicokinetic study according to EFSA guidelines 
 
Devreese M., Osselaere A., De Baere S., De Backer P., Croubels S. 
 
Department of Pharmacology, Toxicology and Biochemistry, Faculty of Veterinary 
Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium 
email: mathias.devreese@ugent.be 
 
Mycotoxins are of great concern in the poultry industry, because of their 
economical impact and the consumers health risk. The occurrence of mycotoxins 
in feedstuffs in Western-Europe is very high, up to 82% (Monbaliu et al., 2010). 
Therefore, a lot of methods for detoxifying mycotoxins have been developed. 
Mycotoxin binders are the most commonly used and seems to be the most 
promising way of counteracting the effects of mycotoxins. To evaluate the 
efficacy of these mycotoxin binders, the European Food Safety Authority (EFSA) 
stipulates that besides in vitro tests, also in vivo tests are mandatory. Moreover, 
these in vivo tests should not be based on non-specific parameters such as 
growth rate and feed conversion, but on ADME studies (absorption, distribution, 
metabolization and excretion) (EFSA, 2010). These ADME studies, or toxicokinetic 
studies, are mainly based on the mycotoxin plasma concentration-time profile 
after oral intake of the mycotoxin with or without binder. 
In this study we evaluated the effect of two commercially available mycotoxin 
binders on different toxicokinetic parameters of T-2 toxin, deoxynivalenol (DON) 
and zearalenon (ZEA). Thirty-six broiler chickens, 17-days old, were divided into 
six different groups as follows: 
Group 1: T-2/DON + BINDER 1 Group 4: ZEA + BINDER 1 
Group 2: T-2/DON + BINDER 2 Group 5: ZEA + BINDER 2 
Group 3: T-2/DON Group 6: ZEA 
 
After a one-week acclimatisation period, the broilers were administered an oral 
bolus of toxin, with or without binder. Next, blood was withdrawn from the vena 
metatarsea plantaris at different time points. 
Plasma was analyzed by a validated LC-MS/MS method for DON, T-2 and ZEA (De 
Baere et al., 2010). To evaluate the efficacy of two mycotoxin binders, different 
toxicokinetic parameters were calculated, e.g. area under the plasma 
concentration-time curve (AUC0  ∞) (WinNonlin 5.0.1, Pharsight Corp., USA). 
Results will be presented at the conference. 
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